ANPEP and cancer: ,46 Thus, the application of cancer-targeting strategies including antibody-drug conjugates (ADCs),47 and peptide-drug conjugate (PDC),48 which are selective to cancer-specific glycoforms of CD13, hold significant promise for cancer-specific therapy.